77 results on '"Cowen, Philip J."'
Search Results
2. Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
3. 12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study
4. Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
5. Adaptive learning from outcome contingencies in eating-disorder risk groups
6. Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task
7. Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case–control study at 7 T
8. A single administration of the antibiotic, minocycline, reduces fear processing and improves implicit learning in healthy volunteers: analysis of the serum metabolome
9. A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents
10. The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
11. Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study.
12. 'It's the way that you look at it'—a cognitive neuropsychological account of SSRI action in depression
13. Constructionism
14. Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
15. The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the 'reflection effect' in healthy adult volunteers
16. Serotonin – in 100 words
17. The Effect of the 5-HT4 Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain.
18. The Potential Use of Ebselen in Treatment-Resistant Depression.
19. Neurokinin-I receptor antagonists as novel antidepressants: trials and tribulations
20. Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task.
21. Decreased sensitivity of 5-HT1D receptors in melancholic depression
22. Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies.
23. No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing.
24. Predictors of Mood Response to Acute Tryptophan Depletion: A Reanalysis
25. Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
26. Abnormalities of Sleep in Patients with the Chronic Fatigue Syndrome.
27. β-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro: Implications for Antidepressant Therapy
28. Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study.
29. Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis.
30. Treatment-resistant depression and peripheral C-reactive protein.
31. Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex.
32. Ultra-High-Field Magnetic Resonance Spectroscopy in Psychiatry.
33. Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers.
34. Cardiovascular and metabolic risk profile in young people at familial risk of depression.
35. Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate.
36. Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
37. Elevated cortical glutamate in young people at increased familial risk of depression.
38. Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.
39. NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers.
40. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action.
41. Effect of a single dose of citalopram on amygdala response to emotional faces.
42. Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression.
43. Human 5-HT Transporter Availability Predicts Amygdala Reactivity In Vivo.
44. Lack of Effect of Tyrosine Depletion on Mood in Recovered Depressed Women.
45. Methamphetamine Activates Reward Circuitry in Drug Naive Human Subjects.
46. State and trait abnormalities in serotonin function in major depression.
47. Decreased sensitivity of 5-HTID receptors in melancholic depression.
48. Repetitive transcranial magnetic stimulation to right prefrontal cortex does not modulate the psychostimulant effects of amphetamine.
49. β-blocker Binding to Human 5-HT1AReceptors in vivoand in vitro: Implications for Antidepressant Therapy.
50. An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.